Breast Cancer Survival Outcomes and Tumor-Associated Macrophage Markers: A Systematic Review and Meta-Analysis.

Eleanor AllisonSenarath EdirimanneJim MatthewsStephen J Fuller

Published in: Oncology and therapy (2022)

Compared to CD68+ TAMs, a high density of CD163+ TAMs that express a similar phenotype to M2 macrophages are a better predictor of poor survival outcomes in breast cancer.

Keyphrases

high density
nk cells
young adults